These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 15225611)

  • 21. Transcription regulation by mutant p53.
    Weisz L; Oren M; Rotter V
    Oncogene; 2007 Apr; 26(15):2202-11. PubMed ID: 17401429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
    Li H; Weinstein IB
    Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of p53 enhances transcription-coupled repair and global genomic repair of a UVC-damaged reporter gene in human cells.
    Dregoesc D; Rybak AP; Rainbow AJ
    DNA Repair (Amst); 2007 May; 6(5):588-601. PubMed ID: 17196445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding sequence-dependent regulation of the human proliferating cell nuclear antigen promoter by p53.
    Shan B; Morris GF
    Exp Cell Res; 2005 Apr; 305(1):10-22. PubMed ID: 15777783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoblastoid cell lines differing in p53 status show clear differences in basal gene expression with minor changes after irradiation.
    Zschenker O; Borgmann K; Streichert T; Meier I; Wrona A; Dikomey E
    Radiother Oncol; 2006 Aug; 80(2):236-49. PubMed ID: 16905214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation.
    Tomso DJ; Inga A; Menendez D; Pittman GS; Campbell MR; Storici F; Bell DA; Resnick MA
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6431-6. PubMed ID: 15843459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time polymerase chain reaction quantitation of relative expression of genes modulated by p53 using SYBR Green I.
    Stagliano KE; Carchman E; Deb S
    Methods Mol Biol; 2003; 234():73-91. PubMed ID: 12824526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable expression of temperature-sensitive p53: a suitable model to study wild-type p53 function in pancreatic carcinoma cells.
    Nuevemann D; Christgen M; Ungefroren H; Kalthoff H
    Oncol Rep; 2006 Sep; 16(3):575-9. PubMed ID: 16865258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional activities of mutant p53: when mutations are more than a loss.
    Kim E; Deppert W
    J Cell Biochem; 2004 Nov; 93(5):878-86. PubMed ID: 15449312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of high-density magnetic field (400 mT at 50 Hz)-induced mutations by wild-type p53 expression in human osteosarcoma cells.
    Miyakoshi J; Mori Y; Yamagishi N; Yagi K; Takebe H
    Biochem Biophys Res Commun; 1998 Feb; 243(2):579-84. PubMed ID: 9480851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC; Zhang T; Lee LH; Shen S
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A tumor specific single chain antibody dependent gene expression system.
    Mary MN; Venot C; Caron de Fromentel C; Debussche L; Conseiller E; Cochet O; Gruel N; Teillaud JL; Schweighoffer F; Tocque B; Bracco L
    Oncogene; 1999 Jan; 18(2):559-64. PubMed ID: 9927213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relationship of p53 and the cytotoxicity mediated by TM-TNF-alpha and S-TNF-alpha].
    Zhu J; Zheng F; Zhang J; Xiong P; Xu Y; Li ZY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):152-4. PubMed ID: 15191714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of recombinant p53 from Sf9 insect cells.
    Sun XZ; Nguyen J; Momand J
    Methods Mol Biol; 2003; 234():17-28. PubMed ID: 12824522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No anti-apoptotic effects of single copies of mutant p53 genes in drug-treated tumor cells.
    Fritzsche C; Zeller G; Knaup KX; Roemer K
    Anticancer Drugs; 2004 Aug; 15(7):679-88. PubMed ID: 15269599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferroptosis in p53-dependent oncosuppression and organismal homeostasis.
    Galluzzi L; Bravo-San Pedro JM; Kroemer G
    Cell Death Differ; 2015 Aug; 22(8):1237-8. PubMed ID: 26143748
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of the human CALM2 calmodulin gene and comparison of the transcriptional activity of CALM1, CALM2 and CALM3.
    Toutenhoofd SL; Foletti D; Wicki R; Rhyner JA; Garcia F; Tolon R; Strehler EE
    Cell Calcium; 1998 May; 23(5):323-38. PubMed ID: 9681195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutant p53 gain-of-function in cancer.
    Oren M; Rotter V
    Cold Spring Harb Perspect Biol; 2010 Feb; 2(2):a001107. PubMed ID: 20182618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.